A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients

Clinical trial NCT01487109 · COMPLETED

Trial details

NCT number: NCT01487109
Sponsor: Concert Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus Chronic Kidney Disease

Start date: 2012-01-01
Primary completion: 2015-01-01
Enrollment: 170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.